Research Overview
The following summarizes areas that published scientific literature has explored. These statements describe research findings in experimental models and are provided for educational purposes only.

Dual GIP / GLP-1 receptor analog.
Optional Temperature Protection $9.99 CAD · 14-day analytical guarantee
What is Tirzepatide?
Tirzepatide is a synthetic peptide investigated as a dual GIP and GLP-1 receptor agonist. It is a subject of metabolic research literature exploring incretin signaling and energy-regulation pathways.
Peptibolics supplies Tirzepatide strictly as a research material for laboratory investigation.
The following summarizes areas that published scientific literature has explored. These statements describe research findings in experimental models and are provided for educational purposes only.
Research has investigated tirzepatide's combined activity at the GIP and GLP-1 receptors, pathways of interest in glucose- and energy-homeostasis science.
Preclinical and clinical literature has examined dual incretin agonists in models of metabolic regulation.
30mg, 10mg
≥99% (HPLC verified)
Every lot of Peptibolics Tirzepatide is verified by third-party laboratory analysis for identity and purity, with a certificate of analysis (COA) available for the corresponding lot.
Every batch is released against this specification. Batch-specific values are printed on the accompanying Certificate of Analysis.
Reconstitute with bacteriostatic water; slow addition along vial wall.
Aseptic aliquoting. Low-bind tubes.
Lyophilised: −20°C. Reconstituted: 2–8°C up to 28 days.
Can't find your answer? Contact our lab team.
Research-use-only labelling does not by itself create a regulatory exemption in Canada. These products are not authorized by Health Canada for human or veterinary use, and purchasers are responsible for confirming that their purchase and use comply with applicable law. See Health Canada's advisory on unauthorized peptides sold online.
It is investigated as a dual GIP/GLP-1 receptor agonist within metabolic research literature.
Each lot is verified for identity and purity by third-party HPLC analysis, with a COA available.
Every batch of Tirzepatide is HPLC-verified to ≥99% purity, mass-confirmed by ESI-MS, and endotoxin-tested to <0.5 EU/mg. A batch-specific Certificate of Analysis is available on this page and inside every shipment.
Orders placed before 14:00 PT ship same-day from Vancouver via tracked courier. Standard transit is 1–3 business days nationwide. Optional Temperature Protection ($9.99 CAD) adds insulated packaging with phase-change coolant to maintain 2–8°C for heat-sensitive orders.
Yes. A signed COA is downloadable directly from this product page and includes HPLC chromatogram, mass spectrum, sequence confirmation, appearance, water content and endotoxin result — traceable to the batch number printed on your vial.
Peptibolics compounds are supplied strictly for in vitro laboratory research. By ordering you confirm you are a qualified researcher or institution and will not administer product to humans or animals. All sales are final.
Regulatory notice: research-use-only labelling does not itself create a regulatory exemption. Not authorized for human or veterinary use. Read Health Canada's advisory on unauthorized peptides.
Research use only. Tirzepatide is supplied strictly for in vitro laboratory research. Not for human or veterinary use. By purchasing you confirm you are a qualified researcher acting within applicable law.
Read our quality standard →